POZEN, Inc.
NASDAQ:POZN
$4.42
-$0.15
(-3.28%)
Quote as of 4:00 PM EST on 02/10/12
Extended Hours:
$4.42
$0.00
(0.00%)
Quote as of 5:15 PM EST on 02/10/12 (NASDAQ)
|
$4.42
-$0.15
(-3.28%)
|
|
| Today's Open | $4.51 |
|---|---|
| Previous Close | $4.57 |
| Daily Range | $4.41 - $4.53 |
| 52-Week Range | $2.15 - $6.39 |
| Market Cap | $132.23M |
| P/E Ratio | -152.33 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 50,085 |
| Average Daily Volume | 90,809 |
| Current FY EPS | $1.29 |
POZN Information
| Description |
|---|
| A pharmaceutical company focused on developing products which can provide improved efficacy, safety or patient convenience in the treatment of acute and chronic pain and pain related conditions. |
| Sector |
| Healthcare |
| Industry |
| Pharmaceuticals |
News & Commentary
5 of Last Week's Biggest Winners
Pozen Inks $75 Million Royalty Deal for Treximet
Pozen's Digital Marketing Plan: A Prescription for the Pharma Industry?
Acadia Pharmaceuticals: Investing With No Safety Net
Pozen Continues Fighting Off Dr. Reddy's Labs
Pozen, AstraZeneca Sue Dr Reddy's Over Vimovo Generic
Pozen: Injunction Stops Par From Selling Generic Of Pozen Drug
FDA Insider Trading: Time for an Overhaul?
Pozen's Success Will Depend on Execution of Unique Marketing Strategies
